WINTON GROUP Ltd Raises Stake in Privia Health Group, Inc. (NASDAQ:PRVA)

WINTON GROUP Ltd increased its stake in Privia Health Group, Inc. (NASDAQ:PRVA) by 1.5% in the fourth quarter, HoldingsChannel.com reports. The firm owned 60,607 shares of the company’s stock after acquiring an additional 902 shares during the quarter. WINTON GROUP Ltd’s holdings in Privia Health Group were worth $1,185,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently made changes to their positions in PRVA. First Horizon Advisors Inc. grew its position in Privia Health Group by 53.8% during the fourth quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company’s stock worth $35,000 after buying an additional 632 shares during the period. EverSource Wealth Advisors LLC boosted its stake in shares of Privia Health Group by 7,833.3% during the 4th quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company’s stock worth $47,000 after acquiring an additional 2,350 shares in the last quarter. Financial Management Professionals Inc. acquired a new stake in shares of Privia Health Group in the 4th quarter worth approximately $51,000. Quarry LP increased its stake in Privia Health Group by 344.6% in the 3rd quarter. Quarry LP now owns 3,268 shares of the company’s stock valued at $60,000 after purchasing an additional 2,533 shares in the last quarter. Finally, Neo Ivy Capital Management acquired a new position in Privia Health Group during the third quarter worth $66,000. Institutional investors and hedge funds own 94.48% of the company’s stock.

Privia Health Group Price Performance

NASDAQ PRVA opened at $22.59 on Friday. The company has a market cap of $2.72 billion, a P/E ratio of 225.92, a P/E/G ratio of 3.47 and a beta of 0.85. Privia Health Group, Inc. has a 12 month low of $15.92 and a 12 month high of $26.04. The company has a 50-day moving average of $23.80 and a 200-day moving average of $21.16.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on the company. Needham & Company LLC restated a “buy” rating and issued a $30.00 price target on shares of Privia Health Group in a research report on Friday, March 21st. Stephens restated an “overweight” rating and set a $26.00 target price on shares of Privia Health Group in a report on Thursday, January 2nd. JPMorgan Chase & Co. upped their price target on shares of Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a report on Friday, November 29th. Canaccord Genuity Group raised their price objective on shares of Privia Health Group from $29.00 to $30.00 and gave the stock a “buy” rating in a research note on Friday, February 28th. Finally, JMP Securities set a $29.00 target price on Privia Health Group in a research note on Friday, February 28th. One investment analyst has rated the stock with a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Buy” and a consensus price target of $26.67.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.